469 related articles for article (PubMed ID: 26560027)
1. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.
Oldridge DA; Wood AC; Weichert-Leahey N; Crimmins I; Sussman R; Winter C; McDaniel LD; Diamond M; Hart LS; Zhu S; Durbin AD; Abraham BJ; Anders L; Tian L; Zhang S; Wei JS; Khan J; Bramlett K; Rahman N; Capasso M; Iolascon A; Gerhard DS; Guidry Auvil JM; Young RA; Hakonarson H; Diskin SJ; Look AT; Maris JM
Nature; 2015 Dec; 528(7582):418-21. PubMed ID: 26560027
[TBL] [Abstract][Full Text] [Related]
2. Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
Wang K; Diskin SJ; Zhang H; Attiyeh EF; Winter C; Hou C; Schnepp RW; Diamond M; Bosse K; Mayes PA; Glessner J; Kim C; Frackelton E; Garris M; Wang Q; Glaberson W; Chiavacci R; Nguyen L; Jagannathan J; Saeki N; Sasaki H; Grant SF; Iolascon A; Mosse YP; Cole KA; Li H; Devoto M; McGrady PW; London WB; Capasso M; Rahman N; Hakonarson H; Maris JM
Nature; 2011 Jan; 469(7329):216-20. PubMed ID: 21124317
[TBL] [Abstract][Full Text] [Related]
3. LMO1 gene polymorphisms contribute to decreased neuroblastoma susceptibility in a Southern Chinese population.
He J; Zhong W; Zeng J; Zhu J; Zhang R; Wang F; Yang T; Zou Y; Xia H
Oncotarget; 2016 Apr; 7(16):22770-8. PubMed ID: 27009839
[TBL] [Abstract][Full Text] [Related]
4. Candidate Gene Association Analysis of Neuroblastoma in Chinese Children Strengthens the Role of LMO1.
Lu J; Chu P; Wang H; Jin Y; Han S; Han W; Tai J; Guo Y; Ni X
PLoS One; 2015; 10(6):e0127856. PubMed ID: 26030754
[TBL] [Abstract][Full Text] [Related]
5. LMO1 polymorphisms and the risk of neuroblastoma: Assessment of meta-analysis of case-control studies.
Hashemi M; Sarabandi S; Karami S; Śmieja J; Moazeni-Roodi A; Ghavami S; Łos MJ
J Cell Mol Med; 2020 Jan; 24(2):1160-1168. PubMed ID: 31830377
[TBL] [Abstract][Full Text] [Related]
6. Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer Polymorphism.
Kandaswamy R; Sava GP; Speedy HE; Beà S; Martín-Subero JI; Studd JB; Migliorini G; Law PJ; Puente XS; Martín-García D; Salaverria I; Gutiérrez-Abril J; López-Otín C; Catovsky D; Allan JM; Campo E; Houlston RS
Cell Rep; 2016 Aug; 16(8):2061-2067. PubMed ID: 27524613
[TBL] [Abstract][Full Text] [Related]
7. Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population.
Al-Absi B; Razif MFM; Noor SM; Saif-Ali R; Aqlan M; Salem SD; Ahmed RH; Muniandy S
Genet Test Mol Biomarkers; 2017 Oct; 21(10):592-599. PubMed ID: 28768142
[TBL] [Abstract][Full Text] [Related]
8.
He J; Zhang X; Zhang J; Zhang R; Yang T; Zhu J; Xia H; Zou Y
J Cancer; 2018; 9(9):1592-1597. PubMed ID: 29760797
[TBL] [Abstract][Full Text] [Related]
9. Indirect Down-regulation of Tumor-suppressive
Saeki N; Saito A; Sugaya Y; Amemiya M; Sasaki H
Cancer Genomics Proteomics; 2018; 15(5):413-420. PubMed ID: 30194082
[TBL] [Abstract][Full Text] [Related]
10. Chromatin Immunoprecipitation and DNA Sequencing Identified a LIMS1/ILK Pathway Regulated by LMO1 in Neuroblastoma.
Saeki N; Saito A; Sugaya Y; Amemiya M; Ono H; Komatsuzaki R; Yanagihara K; Sasaki H
Cancer Genomics Proteomics; 2018; 15(3):165-174. PubMed ID: 29695398
[TBL] [Abstract][Full Text] [Related]
11. Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia.
Oram SH; Thoms J; Sive JI; Calero-Nieto FJ; Kinston SJ; Schütte J; Knezevic K; Lock RB; Pimanda JE; Göttgens B
Leukemia; 2013 Jun; 27(6):1348-57. PubMed ID: 23302769
[TBL] [Abstract][Full Text] [Related]
12. APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL.
Li Z; Abraham BJ; Berezovskaya A; Farah N; Liu Y; Leon T; Fielding A; Tan SH; Sanda T; Weintraub AS; Li B; Shen S; Zhang J; Mansour MR; Young RA; Look AT
Leukemia; 2017 Oct; 31(10):2057-2064. PubMed ID: 28260788
[TBL] [Abstract][Full Text] [Related]
13. ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry.
Wang L; Tan TK; Durbin AD; Zimmerman MW; Abraham BJ; Tan SH; Ngoc PCT; Weichert-Leahey N; Akahane K; Lawton LN; Rokita JL; Maris JM; Young RA; Look AT; Sanda T
Nat Commun; 2019 Dec; 10(1):5622. PubMed ID: 31819055
[TBL] [Abstract][Full Text] [Related]
14. Genetic predisposition to neuroblastoma results from a regulatory polymorphism that promotes the adrenergic cell state.
Weichert-Leahey N; Shi H; Tao T; Oldridge DA; Durbin AD; Abraham BJ; Zimmerman MW; Zhu S; Wood AC; Reyon D; Joung JK; Young RA; Diskin SJ; Maris JM; Look AT
J Clin Invest; 2023 May; 133(10):. PubMed ID: 37183825
[TBL] [Abstract][Full Text] [Related]
15.
He L; Zhu J; Han F; Tang Y; Zhou C; Dai J; Wang Y; Zhou H; He J; Wu H
Front Oncol; 2018; 8():468. PubMed ID: 30406033
[No Abstract] [Full Text] [Related]
16.
Li G; Jia W; Yin Z; Zhu J; Liu G; Xia H; He J; Fu W
J Cancer; 2019; 10(8):1808-1813. PubMed ID: 31205537
[TBL] [Abstract][Full Text] [Related]
17. LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis.
Zhu S; Zhang X; Weichert-Leahey N; Dong Z; Zhang C; Lopez G; Tao T; He S; Wood AC; Oldridge D; Ung CY; van Ree JH; Khan A; Salazar BM; Lummertz da Rocha E; Zimmerman MW; Guo F; Cao H; Hou X; Weroha SJ; Perez-Atayde AR; Neuberg DS; Meves A; McNiven MA; van Deursen JM; Li H; Maris JM; Look AT
Cancer Cell; 2017 Sep; 32(3):310-323.e5. PubMed ID: 28867147
[TBL] [Abstract][Full Text] [Related]
18. FGF represses metastasis of neuroblastoma regulated by MYCN and TGF-β1 induced LMO1 via control of let-7 expression.
Wang XH; Wu HY; Gao J; Wang XH; Gao TH; Zhang SF
Brain Res; 2019 Feb; 1704():219-228. PubMed ID: 30321496
[TBL] [Abstract][Full Text] [Related]
19. CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants.
Spisák S; Lawrenson K; Fu Y; Csabai I; Cottman RT; Seo JH; Haiman C; Han Y; Lenci R; Li Q; Tisza V; Szállási Z; Herbert ZT; Chabot M; Pomerantz M; Solymosi N; ; Gayther SA; Joung JK; Freedman ML
Nat Med; 2015 Nov; 21(11):1357-63. PubMed ID: 26398868
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells.
Wright JB; Brown SJ; Cole MD
Mol Cell Biol; 2010 Mar; 30(6):1411-20. PubMed ID: 20065031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
